APEX INNOVATIVE SCIENCES
Apex Innovative Sciences is an independent clinical trial site operator focusing on clinical trial studies for central nervous system indications and other therapeutic areas, including neurology, psychiatry, addiction, and others. Apex delivers the highest scientific and clinical quality for its client partners and participants.
APEX INNOVATIVE SCIENCES
Industry:
Clinical Trials Health Care Product Research
Founded:
2019-01-01
Address:
Garden Grove, California, United States
Country:
United States
Website Url:
http://www.apexsci.com
Total Employee:
11+
Status:
Active
Contact:
(866)267-8742
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Gravity Forms Network Solutions DNS Apple ICloud Mail Sendgrid Network Solutions Proofpoint
Similar Organizations
Galenea
Galenea is engaged in developing therapeutics for central nervous system diseases.
Neoclinical
Neoclinical matches clinical trials with the patients that need them the most.
OxyNov inc
OxyNov focuses on clinical innovation and specializes in designing and commercializing innovative medical devices.
Investors List
Bison Capital Asset Management
Bison Capital Asset Management investment in Private Equity Round - Apex Innovative Sciences
Official Site Inspections
http://www.apexsci.com
- Host name: 209.17.116.160
- IP address: 209.17.116.160
- Location: Jacksonville United States
- Latitude: 30.1426
- Longitude: -81.5727
- Metro Code: 561
- Timezone: America/New_York
- Postal: 32258
More informations about "Apex Innovative Sciences"
Scientific Affairs Team - apexsci.com
An accomplished clinical researcher, basic scientist, and psychiatric pharmacist, Dr. English joined Apex in 2021 to provide strategic direction and leadership to the Scientific Affairs team, โฆSee details»
Apex Science - Crunchbase Company Profile & Funding
Apex Science provides analytical support for liquid chromatography techniques. The company offers a range of services including analytical support, method development, and analyses.See details»
Apex Innovative Sciences - Datanyze
Www.apexsci.com Apex Innovative Sciences Profile and History Apex Innovative Sciences provides high-quality clinical trial conduct for a wide range of Phase I-IV studies as well as โฆSee details»
Scientific Advisory Board - apexsci.com
Dr. Tracy is the founder and President of NI Research (NIR), the leading publisher of independent research on the neurotherapeutics industry. NIRโs bimonthly publication, NeuroPerspective, โฆSee details»
Mitch Hassman, MBA - apexsci.com
Feb 2, 2022 Apex Innovative Sciences is a leading independent operator of clinical trial sites focused primarily on studies in healthy volunteers and central nervous system indications.See details»
Apex Sale PRv4 - bisoncapital.com
Www.apexsci.com ABOUT BISON CAPITAL Bison Capital is a Los Angeles and New York based private equity ๏ฌrm that makes growth capital investments in middleโ market companies, public โฆSee details»
CenExel (formerly Apex Innovative Sciences) - SignalHire
Organization Website: apexsci.com : Social Links: Phone Number (866)267-8742: CenExel (formerly Ap... industries R&D: CenExel (formerly Ap... Employees Size 200-500 employees: โฆSee details»
Apex Innovative Sciences - Overview, News & Similar ... - ZoomInfo
High-Quality Phase I-IV Clinical Trial Conduct GARDEN GROVE, Calif. and MARLTON, N.J., March 8, 2022 /PRNewswire/ -- Apex Innovative Sciences ("Apex" or the "Company"), a โฆSee details»
Apex Innovative Sciences - Crunchbase Company Profile & Funding
Apex Innovative Sciences is an independent clinical trial site operator focusing on clinical trial studies for central nervous system indications and other therapeutic areas, including โฆSee details»
Apex Innovative Sciences, Inc. in Garden Grove, CA - (714) 799-7799
Apex Innovative Sciences, Inc. is in the Medical Research, Commercial business. View competitors, revenue, employees, website and phone number.See details»
Apex Innovative Sciences - Products, Competitors, Financials, โฆ
Apexsci.com. Overview & Products; Financials; Founded Year 2019. Stage Acquired | Acquired. About Apex Innovative Sciences. As of June 16th, 2022, Apex Innovative Sciences was โฆSee details»
Apex Innovative Sciences Careers - Levels.fyi
Apexsci.com Website. 2019 Year Founded. 351 # of Employees. $10M-$50M Estimated Revenue. Headquarters. Get Verified Salaries in your Inbox. Subscribe to verified offers. Youโll get the โฆSee details»
Apex Innovative Sciences - Bison Capital Asset Management, LLC.
Apex Innovative Sciences, Inc. was formed in September 2019 through the merger of CNS Network (www.cnstrial.com), Hassman Research Institute (www.hritrials.com), and Clinical โฆSee details»
Psychedelics Research - apexsci.com
Apex receives high-level guidance and advice to ensure the greatest possible competency for psychedelics studies from Scientific Advisory Board member, Reid Robison, M.D., MBA, an โฆSee details»
Apex Innovative Sciences - Company Info, Employees & Competitors
View Apex innovative sciences apexsci.com location in United states, revenue, industry and description. Find related and similar companies as well as employees by title and much more. โฆSee details»
Apex Innovative Sciences - PitchBook
Jan 1, 2019 Information on acquisition, funding, investors, and executives for Apex Innovative Sciences. Use the PitchBook Platform to explore the full profile.See details»
Apex Science - HOME
Utilizando-se de abordagem científica aliada à utilização do estado da arte da instrumentação analítica, a Apex Science visa fornecer aos seus parceiros soluções de alta qualidade frente โฆSee details»
FocalPoint Advises Apex Innovative Sciences on its Corporate ...
Jan 3, 2022 Long Beach, CA -- Apex Innovative Sciences, Inc. (โApexโ or the โCompanyโ), a clinical research and site service organization specializing in complex early phase studies, has โฆSee details»
OKX Ventures insight: how decentralization is transforming the ...
1 day ago The forces of decentralization are now being felt in the scientific community as DeSci โ decentralized science โ continues to emerge. Still in its infancy, the DeSci seeks to โฆSee details»
Evan Ohlemutz - apexsci.com
Cyclerion Therapeutics presented positive topline data today, July 28, 2022, during a webinar on their C6463-103 Phase 1 Schizophrenia studyโฆ Continue reading CenExel Two-Site Solution โฆSee details»